Cost-Effectiveness Analysis of OnabotulinumtoxinA (BOTOX(®)) for the Management of Urinary Incontinence in Adults with Neurogenic Detrusor Overactivity: A UK Perspective

OBJECTIVES: To evaluate the cost effectiveness of onabotulinumtoxinA (BOTOX(®), 200 units [200 U]) for the management of urinary incontinence (UI) in adults with neurogenic detrusor overactivity (NDO) due to subcervical spinal cord injury or multiple sclerosis that is not adequately managed with ant...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pharmacoeconomics
Auteurs principaux: Hamid, Rizwan, Loveman, Clara, Millen, Jim, Globe, Denise, Corbell, Catherine, Colayco, Danielle, Stanisic, Sanja, Gultyaev, Dmitry
Format: Artigo
Langue:Inglês
Publié: Springer International Publishing 2014
Sujets:
Original Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4381108/
https://ncbi.nlm.nih.gov/pubmed/25526842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-014-0245-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires